ANZCHOG Australian Children's Cancer Trails
Sign in
Forgot password
Home
Trials
Diseases
All Tumour Types
Bone marrow transplant
Brain and Spinal Tumours
Leukaemia
Lymphoma
Non cancer haematology
Solid tumours
About Us
Links
FAQ
Keyword or Protocol ID
View all trials
Disease
All diseases
All Tumour Types
Bone marrow transplant
Brain and Spinal Tumours
Leukaemia
Lymphoma
Non cancer haematology
Solid tumours
Location
All locations
Children's Hospital at Westmead
Christchurch Hospital
John Hunter Children's Hospital
Lady Cilento Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Princess Margaret Hospital
Royal Children's Hospital Melbourne
Starship Children's Hospital
Sydney Children's Hospital
Women and Children's Hospital
Yet to be confirmed
Advanced search
Home
/
Trials
/
Trial
Are you a member? Sign in above to view additional information
Study title
NANT 2012-01 Phase I Study of Fifluoromethylornithine (DFMO) and Celecoxib with Cyclophosphamide/Topotecan for patients with relapsed or refractory Neuroblastoma.
Protocol ID
N2012-01
Disease
Disease Type
Disease Subtype
Solid tumours
Neuroblastoma
Eligibility criteria
Study Status
Open
Location(s)
Sydney Children's Hospital
Centre Study Status:
Open
Notes:
Phase
Phase 1
Study type
Treatment
Diagnosis stage
Relapse/refractory
Study open date
02/07/2014
Study close date
N/A
Study chair
Sponsor
Sydney Children's Hospital Network
Back to search results